These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6539448)

  • 21. Adverse side effects of metrizamide in myelography.
    Gelmers HJ
    Neuroradiology; 1979 Sep; 18(3):119-23. PubMed ID: 492514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complications of Metrizamide (amipaque) myelography.
    Stewart JR; Thorne RP
    Orthop Nurs; 1985; 4(4):53-4. PubMed ID: 2981040
    [No Abstract]   [Full Text] [Related]  

  • 23. A prospective clinical trial comparing metrizamide and iohexol for equine myelography.
    Widmer WR; Blevins WE; Jakovljevic S; Levy M; Teclaw RF; Han CM; Hurd CD
    Vet Radiol Ultrasound; 1998; 39(2):106-9. PubMed ID: 9548136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Transient encephalopathy following cervical myelography with metrizamide].
    Kessler A; Radwan H; Kott E
    Harefuah; 1988 May; 114(9):435-7. PubMed ID: 3396999
    [No Abstract]   [Full Text] [Related]  

  • 25. Influence of certain factors on the manifestations of the adverse effects of metrizamide myelography.
    Yu YL; du Boulay GH; Paul E
    Neuroradiology; 1986; 28(4):339-43. PubMed ID: 3762912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serial EEG recordings following intrathecal metrizamide administration.
    Drory VE; Neufeld MY; Avrahamy E; Korczyn AD
    Clin Electroencephalogr; 1989 Jul; 20(3):202-8. PubMed ID: 2752591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contrast agents for myelography: clinical and radiological evaluation of Amipaque and Pantopaque.
    Kieffer SA; Binet EF; Esquerra JV; Hantman RP; Gross CE
    Radiology; 1978 Dec; 129(3):695-705. PubMed ID: 103130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accelerated hypertension associated with the central nervous system toxicity of metrizamide.
    Rodman MD; White WB
    Drug Intell Clin Pharm; 1986 Jan; 20(1):62-3. PubMed ID: 3943459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequelae of metrizamide myelography in 200 examinations.
    Baker RA; Hillman BJ; McLennan JE; Strand RD; Kaufman SM
    AJR Am J Roentgenol; 1978 Mar; 130(3):499-502. PubMed ID: 415557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metrizamide: a review with emphasis on drug interactions.
    Hanus PM
    Am J Hosp Pharm; 1980 Apr; 37(4):510-3. PubMed ID: 6103672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Side effects of cervical myelography/radiculography with metrizamide (Amipaque)].
    Lesak F
    Ugeskr Laeger; 1986 Nov; 148(47):3134-6. PubMed ID: 3810908
    [No Abstract]   [Full Text] [Related]  

  • 32. The indications for metrizamide myelography. Relationship with complications after myelography.
    Herkowitz HN; Romeyn RL; Rothman RH
    J Bone Joint Surg Am; 1983 Oct; 65(8):1144-9. PubMed ID: 6630258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropsychologic reactions and other side effects after metrizamide myelography.
    Hauge O; Falkenberg H
    AJR Am J Roentgenol; 1982 Aug; 139(2):357-60. PubMed ID: 6979893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Spinal dural arteriovenous fistulae: exacerbation after myelography with metrizamide].
    Roullet E; Netter JM; Chiras J; Mahieux F; Amarenco P; Marteau R
    Rev Neurol (Paris); 1988; 144(5):371-5. PubMed ID: 3420355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myelography with the non-ionic water-soluble contrast medium metrizamide.
    Hindmarsh T
    Acta Radiol Diagn (Stockh); 1975 Sep; 16(5):417-35. PubMed ID: 1199781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metrizamide-phenothiazine interaction. Report of a case with seizures following myelography.
    Hindmarsh T; Grepe A; Widén L
    Acta Radiol Diagn (Stockh); 1975 Mar; 16(2):129-34. PubMed ID: 810000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complications of lateral C1-2 puncture myelography.
    Katoh Y; Itoh T; Tsuji H; Matsui H; Hirano N; Kitagawa H
    Spine (Phila Pa 1976); 1990 Nov; 15(11):1085-7. PubMed ID: 2267601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metrizamide encephalopathy.
    Vincent FM; Zimmerman JE
    Ann Neurol; 1980 May; 7(5):494. PubMed ID: 7396431
    [No Abstract]   [Full Text] [Related]  

  • 39. Visual evoked response changes following intrathecal injection of water-soluble contrast media: a possible method of assessing neurotoxicity and a comparison of metrizamide and iopamidol.
    Broadbridge AT; Bayliss SG; Firth R; Farrell G
    Clin Radiol; 1984 Sep; 35(5):371-3. PubMed ID: 6547888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positioning of patients after metrizamide lumbar myelography.
    Robertson WD; Lapointe JS; Nugent RA; Robinson RG; Daly LF
    AJR Am J Roentgenol; 1980 May; 134(5):947-8. PubMed ID: 6768270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.